Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03032393 · ClinicalTrials.gov registry record · NA
The Effect of Power Posing on Timed Up and Go Test Score
A NA study, sponsored by Youngstown State University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03032393: Completed NA study, sponsored by Youngstown State University.
NCT03032393 is a NA study that has completed, run by Youngstown State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03032393, a NA study, has completed, sponsored by Youngstown State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study determines the effects of posture on time up and go test. Half of the subjects will assume a high-power posture, while the other half will assume a low-power posture.
Primary Outcome
Patients wear their regular footwear and can use a walking aid if needed. Begin by having the patient sit back in a standard arm chair and identify a line 3 meters or 10 feet away on the floor. The timed up and go test measures the amount of time, in seconds, that it takes to stand from a chair, walk 3 meters, turn around and walk back to the chair, and sit down again. A change between pre and post postural intervention is reported. The time point for pre intervention is at baseline. The time p
Interventions
- OTHER high-power
- OTHER low-power
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-02-03 |
| Est. Completion | 2017-12-31 |
| Phase | NA |
What the finished NCT03032393 record still lists
NCT03032393 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which high-power is the first listed.
NCT03032393 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03032393 about?
NCT03032393 is a clinical study titled "The Effect of Power Posing on Timed Up and Go Test Score". This study determines the effects of posture on time up and go test. Half of the subjects will assume a high-power posture, while the other half will assume a low-power posture.
What is the current status of trial NCT03032393?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-02-03. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT03032393?
The interventions under investigation include: high-power (OTHER), low-power (OTHER).
Who is sponsoring clinical trial NCT03032393?
This trial is sponsored by Youngstown State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03032393's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI